Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study

OBJECTIVE: The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease. METHODS: A total of 120 newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Jianfang, Fu, Wanxia, Xiao, Xiling, Gao, Jing, Xu, Wenjuan, Yang, Jianrong, Liu, Qingzhen, He, Kaiyan, Ma, Jingxuan, Lian, Taixiong, Chen, Qian, Xu, Mengying, Li, Jie, Ming, Qiuhe, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250100/
https://www.ncbi.nlm.nih.gov/pubmed/37305429
http://dx.doi.org/10.1155/2023/2044090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250100/
https://www.ncbi.nlm.nih.gov/pubmed/37305429
http://dx.doi.org/10.1155/2023/2044090

Ejemplares similares